
Zuvicin 100mg Injection
Marketer
Zuventus Healthcare Ltd
Salt Composition
Epirubicin (100mg)
Overview Zuvicin 100mg Injection
Injected Zuvicin (100mg) treats various hematologic, breast, gastric, pulmonary, ovarian, and soft-tissue cancers. It also aids in preventing bladder cancer recurrence post-surgery. Administered intravenously (IV) by a healthcare professional, it's used alone or in combination chemotherapy regimens, with dosage and frequency determined by your physician based on your condition. Strict adherence to the prescribed regimen is crucial, as misuse can lead to severe adverse reactions. Therapeutic benefits might not be immediately apparent; discontinue only upon medical instruction. Because it impairs contraceptive efficacy, reliable birth control is recommended for both partners throughout treatment. Frequent side effects include nausea, thrombocytopenia, alopecia, amenorrhea, pyrexia, and dermatologic reactions. Leukopenia increases infection risk, potentially life-threatening. Regular blood tests are essential to monitor hematologic parameters and hepatic, renal, and cardiac function. Prior to treatment, disclose any pre-existing liver or heart conditions, and provide a complete medication history to avoid drug interactions impacting efficacy. Report pregnancy or breastfeeding to your physician.
Primary Ingredients of Zuvicin 100mg Injection
No text provided. Please provide the text you wish to be rewritten.
Uses of Zuvicin 100mg Injection
Malignant neoplasm
Major Benefits of Zuvicin 100mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Zuvicin 100mg Injection:
- Low blood platelets
- Nausea
- Hair loss
- Absence of menstrual periods
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Weight loss
- Decreased white blood cell count (neutrophils)
- Hot flashes
- Gastrointestinal inflammation
- Rash
- Low energy
- Eye disorder
How to use Zuvicin 100mg Injection:
This medication will be administered by your healthcare provider; self-medication is strongly discouraged.
How Zuvicin 100mg Injection works:
The anti-neoplastic agent, Zuvicin 100mg Injection, targets breast cancer cells by inhibiting topoisomerase II, a crucial enzyme in DNA replication. This inhibition, coupled with the generation of cytotoxic free radicals, leads to DNA damage, thus impeding cancer cell proliferation and ultimately inducing cell death.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zuvicin 100mg Injection and alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Administering Zuvicin 100mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential advantages outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administering Zuvicin 100mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Driving ability may be compromised by Zuvicin 100mg Injection side effects. Nausea and vomiting, potential side effects of Zuvicin 100mg Injection, can temporarily impair driving skills.
KidneySAFE IF PRESCRIBED
The use of Zuvicin 100mg Injection in individuals with kidney impairment is likely safe. Current evidence indicates dose modification may be unnecessary; however, medical advice is recommended. For patients exhibiting serum creatinine exceeding 5 mg/dL, reduced dosages might be appropriate.
LiverCAUTION
Exercise caution when administering Zuvicin 100mg Injection to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before use. Zuvicin 100mg Injection is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Zuvicin 100mg Injection :
NA
Facts to Know About Zuvicin 100mg Injection
| Label | Value |
|---|---|
| Chemical Classification | Anthracycline Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Cytotoxic alkaloids |
